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Background: Synthesized arylidene derivatives of rhodanine and 2,4-thiazolidiendione have potent
pharmacological activities, and these are also key substrates for the preparation of clinically used antidiabetics.
Findings: Some 1,1,3,3-tetramethylguanidine-based task-specific ionic liquids (TSILs) 1a-1e were prepared and
employed to the catalyzed solvent-free Knoevenagel condensation of 2,4-thiazolidinedione 3a and rhodanine 3b
with a variety of aldehydes.
Conclusions: Best results were obtained with 1,1,3,3-tetramethylguanidine lactate ([TMG][Lac]) 1c. The TSIL used
can be easily recovered and recycled, yielding products 4–5 in excellent yields under ultrasonic environment
without the formation of any side products or toxic waste.
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Background
2,4-thiazolidenedione (TZD) is an attractive scaffold be-
cause of its prestigious position in medicinal chemistry
as this unit is responsible for numerous pharmacological
and biological activities, e.g., antidiabetic [1,2], antidiarrheal
[3], anticonvulsant [4], antimicrobial [5], antihistaminic [6],
anticancer [7], anti-HIV [8], 15-hydroxyprostaglandin de-
hydrogenase inhibitors [9], and anti-ischemic [10]. The
position of these molecules seems to be most significant as
they are a subset of commercially employed non-insulin-
dependent diabetes mellitus and insulin-sensitizing agents
(Figure 1) such as rosiglitazone, epalrestat, ciglitazone, AD-
5061, pioglitazone, and so on.
Several methods have been developed for their con-
densation with aldehydes as this is a crucial step in the
production of the above clinically used drugs (Figure 1),
and thus, this condensation is of commercial value. To
achieve this end, several production protocols are repor-
ted employing several catalysts used such as amines [11],
amine derivatives [12], amines salts [13], baker's yeast
[14], sodium acetate [15-17], glycine [18,19], KF-Al2O3* Correspondence: jind_suresh7@rediffmail.com
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reproduction in any medium, provided the orig[20], and ionic liquids [21-25]. Several of these existing
protocols for achieving this step have drawbacks like
having long reaction times and low yields and leaving
toxic residues on aqueous work-up; amine use is also
now found to be carcinogenic. In addition, ionic liquids
used earlier to accelerate this reaction are not environ-
mentally benign because their preparation involves the
harmful chemical intake, that is, volatile solvent and cor-
rosive/toxic reagents [21-25]. Hence, a facile efficient
process is still desirable. In search of greener chemical
process development, ionic liquids are finding a pro-
minent place [26-30]; herein, we report the first-ever
sonically enhanced procedure using the environmentally
benign ionic liquid 1,1,3,3-tetramethylguanidine lactate
([TMG][Lac]).
This ionic liquid based on TMGs is stable and easy to
prepare in the laboratory, e.g., [TMG][Lac] 1c is pre-
pared by neutralizing TMG with lactic acid [31]. [TMG]
[Lac] has already been reported to accelerate important
reactions such as Henry reactions, hydrogenation of ole-
fins, hydrogenolysis of glycerol, aldol reaction, and so on
[32-38]. Our own interest in ionic liquids (ILs) and in
green synthetic transformations [29,30] prompted us to
explore the catalytic activities of TMG-based ILs in the
synthesis of 2-TZD and rhodanine derivatives. On top ofThis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
































Figure 1 Clinically used molecules having 5-arylidene rhodanines and 2,4-thiazolidenediones.
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saves time and is environmentally friendly [39-41].
Results and discussion
In our initial pilot experiments, ionic liquids 1a-1e based
on TMGs were used to catalyze condensation of 4-metho-
xybenzaldehyde 2a with 2,4-thiazolidinedione 3a (Table 1).
The best results were obtained when the reaction was cat-
alyzed by task-specific ionic liquid (TSIL) [TMG][Lac] 1c
under ultrasound irradiations at 80°C for 20 min (Table 1,
entry 3) among the ILs 1a-1e. The amount of catalyst 1c
was also established as 20 mol% by carrying out reac-
tions of 2a with 3a using different amounts of cata-
lyst (5 to 50 mol%).
To check the effect of catalyst, temperature, and ultra-
sound irradiations, a set of reactions was performed
using different reaction conditions such as heating alone
(Table 2, entry 2), ultrasound alone (Table 2, entries
6 and 7), heating along with ultrasound irradiations
(Table 2, entries 5 to 10), and in the absence of both
(Table 2, entry 1). Conclusively, catalyst, temperature,
and ultrasound irradiations are all equally importantTable 1 Synthesis of (Z)-5-(4-methoxybenzylidene)thiazolidin
3a employing different ILs as catalyst











The reaction conditions for (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione 4a a
irradiated under ultrasound irradiations at 80°C. The product was characterized by s
after recrystallization.to accelerate the Knoevenagel condensation of arylalde-
hydes 2 and 2,4-thiazolidenedione/rhodanine 3 to afford
5-arylidene-2,4-thiazolidinediones and 5-arylidenerhoda-
nines 4–5 with excellent yields (Table 2, entry 9).
Further, a variety of carbonyl compounds such as
aromatic aldehydes 2a-2b, heterocyclic aldehydes 2c-2e
(furan-2-carbaldehyde 2c, thiophene-2-carbaldehyde 2d,
and 3-formylchromone 2e) were condensed with 5-mem-
bered active hydrogen compounds 2,4-thiazolidinedione
3a and rhodanine 3b in the presence of 20 mol% 1c under
ultrasound irradiations at 80°C under solvent-free condi-
tions to provide Knoevenagel products 4–5 in excellent
yields (Scheme 1). Aromatic aldehydes 2a-2b afforded ex-
cellent yields in a shorter reaction time, whereas hetero-
cyclic 2c-2e gave high yields in a slightly long reaction
time (Table 3).
Active methylene compounds 3a-3b afforded the
Knoevenagel products selectively with exo-double bond
without the formation of other side products/bis-pro-
ducts as shown in Scheme 2. Electron-withdrawing and
electron-donating groups on aromatic aldehyde showed
a slight diversion in the rate of reaction and yields, i.e.,e-2,4-dione 4a via Knoevenagel condensation of 2a with






re as follows: 2a (1 mmol), 3a (1 mmol), and catalysts (20 mol%) were
pectral techniques like IR, 1H NMR, 13C NMR, and mass spectra. aIsolated yields
Table 2 Condensation of 2a and 3a in the presence of
different reaction conditions
Entry Catalyst Time (min) Yielda
1 No catalyst + No Heating + No US 180 -
2 No catalyst + Heating (50°C) 180 -
3 Catalyst (20 mol%) + Heating (50°C) 60 <55
4 Catalyst (20 mol%) + Heating (80°C) 60 68
5 No catalyst + Heating (50°C) + US 120 <10
6 Catalyst (20 mol%) + No Heating + US 50 74
7 Catalyst (50 mol%) + No Heating + US 50 72
8 Catalyst (20 mol%) + Heating (50°C) + US 40 80
9 Catalyst (20 mol%) + Heating (80°C) + US 20 95
10 Catalyst (20 mol%) + Heating (100°C) + US 30 92
The different reaction conditions are as follows: 1a (1 mmol), 2a (1 mmol), and
catalysts were irradiated under ultrasound irradiations (US) at different
temperatures. aIsolated yield.
Suresh and Sandhu Organic and Medicinal Chemistry Letters 2013, 3:2 Page 3 of 6
http://www.orgmedchemlett.com/content/3/1/2the electron-withdrawing group containing aromatic al-
dehydes afforded arylidene compounds 4–6 with better
yields in a shorter reaction time (Table 3).
Next, the recyclability of the catalyst 1c was studied
using 2a and 3a as the model substrate. We observed
that 1c could be recovered by extraction of the filtrate
with a particular solvent, and pure IL (colorless oil) was
obtained after drying the water-rich layer under vacuum.
The recovered catalyst was successfully recycled and
reused for five runs.
As plausible reaction mechanism is concerned, 1c cat-
alyzed synthesis of arylidene products 4–5 by facilitating
the nucleophilic attack of 3a-3b (lactate anion abstract
the active hydrogen of 3) on the electrophilic carbon of
carbonyl compounds (activated by TGA cation) 2a-2e,
and subsequent dehydration leads to the product forma-
tion (Scheme 2).
Conclusion
In summary, we have disclosed a clean and efficient
procedure for the synthesis of pharmacologically signifi-
cant thiazolidine derivatives via Knoevenagel condensa-









2a: R=4-MeO-C6H4, 2b: R=
2d: R=2-thiophene, 2e: R=3
US
Scheme 1 Knoevenagel reaction of 2 and 3 catalyzed by 1c.The task-specific ionic liquid [TMG][Lac] catalyst used
is biodegradable, recyclable, and purely environmentally
benign as it is easy to prepare, without the involvement
of any harmful solvents/chemicals [31]; hence, it is bet-
ter than already used imidazolium-based ionic liquids
[21-25] as catalysts. The scope is fairly large as the range
of aldehydes and active methylene compounds used
afforded products in very good to excellent yields. Other
prominent features are as follows: the reaction time is
shorter, no polluting volatile solvents are used, reaction
work-up is simple, no toxic by-products are formed dur-
ing aqueous work-up, and all these green aspects place
this method at an advantageous position compared to




All starting materials were commercial products and
were used without further purification except liquid al-
dehydes, which were distilled before use. Yields refer to
yield of the isolated products. Melting points were de-
termined in open capillaries in a paraffin bath and are
uncorrected. Nuclear magnetic resonance spectra were
obtained on a 400 MHz Bruker AMX instrument (Bruker
Corporation, Billerica, MA, USA) in DMSO-d6 using
TMS as a standard. HRMS analyses were carried out using
a ESI-Q TOF instrument (Bruker Corporation). Infrared
spectra were recorded using a Shimadzu FT-IR-8400 s
spectrophotometer (Shimadzu Corporation, Kyoto, Japan)
as KBr pellets. All the reactions were studied using a
SIDILU Indian-made sonic bath (Sidilu Ultrasonic Tech-
nology, Bangalore India) working at 35 kHz (constant fre-
quency, 120 W) maintained at 80°C without mechanical
stirring.
General procedure for the synthesis of arylidene-
thiazolidenes
A mixture of aldehyde (1 mmol), 2,4-thiazolidinedione/
rhodanine (1 mmol), and [TMG][Lac] (20 mol%) was ir-
radiated under ultrasonic irradiation at 80°C for a few4-5=O
=S
0 mol%)







Table 3 [TMG][Lac]-catalyzed solvent-free reactions of
thiazolidines 3 with aldehydes 2
Entry Aldehydes Thiazolidenes Producta Time (min) Yield (%)b
1 2a 3a 4a 20 95
2 2b 3a 4b 15 98
3 2c 3a 4c 25 91
4 2d 3a 4d 30 92
5 2e 3a 4e 20 96
6 2a 3b 5a 15 97
7 2b 3b 5b 10 99
8 2c 3b 5c 20 92
9 2d 3b 5d 25 91
10 2e 3b 5e 15 98
aReaction conditions: 2a-2e (1 mmol), 3a-3b (1 mmol), and 1c (20 mol%) were
irradiated under ultrasound irradiations at 80°C. The products were
characterized by spectral techniques like IR, 1H NMR, 13C NMR, and mass
spectra. bIsolated yields after recrystallization.
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monitored via thin layer chromatography. After the reac-
tion completion, the reaction mass was cooled (15°C to
20°C) and stirred with water (10 mL) for 30 min. The
solid product was filtered and dried. The obtained prod-
ucts were recrystallized in EtOH/DMF (3:2). The prod-
ucts 4–5 were confirmed by their spectral data after
comparison with authentic samples, infrared (IR), proton
nuclear magnetic resonance (1H NMR), mass spectra,
and melting points.General procedure for the recovery of [TMG][Lac]
Further, the obtained filtrate was extracted with diethyl
ether (3 × 10 mL), and the aqueous layer was dried
under pressure. IL as a colorless oil was obtained which






















Scheme 2 The possible reaction mechanism for the Knoevenagel reacSpectral data of reprehensive compounds
The following are the spectral data for 4a, 4e, 5b,
and 5e:
 (4a): Mp. 249°C to 250°C, IR (KBr, cm−1): 3393,
1671, 1605, 1434, 1201; 1H NMR (300 MHz,
DMSO-d6) δ 3.09 (s, 3H), 7.08 (d, 2H, J = 8.2 Hz),
7.52 (d, 2H, J = 8.2 Hz), 7.61 (s, 1H), 13.71 (s, 1H).
Analysis calculated for C11H9NO2S2: C, 52.57%; H,
3.61%; N, 5.57%; S, 25.52%; found: C, 52.78%; H,
3.95%; N, 5.48%; S, 25.79%
 (4e) Mp.: 259°C to 260°C, IR (KBr, cm−1): 1647
(γ pyrone CO); 1H NMR δ 7.54 (ddd, 1H, 6-H),
7.62 (s, 1H, C = C-H), 7.71 (d, 1H, J8,7 = 8.41 Hz,
8-H), 7.98 (ddd, 1H, 7-H), 8.17 (dd, 1H,
J5,6 = 8.41 Hz, J5,7 = 1.68 Hz, 5-H), 8.83 (s, 1H,
2-H), 12.41 (s, 1H, NH). Analysis calculated for
C13H7NO3S2: C, 53.98%; H, 2.42%; N, 4.84%;
S, 22.15%; found: C, 53.84%; H, 2.74%; N, 4.95%;
S, 21.96%
 (5b): Mp. 268°C to 269°C. IR (KBr, cm−1):
3148, 1719, 1610; 1H NMR (300 MHz,
DMSO-d6) δH: 7.53 (2H, m), 7.72 (2H, m), 7.76
(1H, s), 12.65 (1H, bs). Analysis calculated for
C10H6ClNO2S: C, 50.11%; H, 2.52%; N, 5.84%;
S, 13.38%; found: C, 49.87%; H, 2.63%; N, 5.92%;
S, 13.78%
 (5e) Mp.: 290°C, IR (KBr, cm−1): 1637
(γ pyrone CO); 1H NMR: δ 7.58 (ddd, 1H, 6-H),
7.61 (s, 1H, C = C-H), 7.74 (d, 1H, J8,7 = 8.40 Hz,
8-H), 7.88 (ddd, 1H, 7-H), 8.13 (dd, 1H,
J5,6 = 8.40 Hz, J5,7 = 1.60 Hz, 5-H), 8.85 (s, 1H,
2-H), 12.48 (s, 1H, NH). Analysis calculated for
C13H7NO4S: C 57.14%, H 2.58%, N 5.13%, S
































tion catalyzed by TSIL.
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